Cart
sales@molnova.com
USP8-IN-22c
CAS No. 924296-17-3
USP8-IN-22c( —— )
Catalog No. M16621 CAS No. 924296-17-3
A potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.56 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 341 | In Stock |
|
| 2MG | 188 | In Stock |
|
| 5MG | 326 | In Stock |
|
| 10MG | 466 | In Stock |
|
| 25MG | 744 | In Stock |
|
| 50MG | 1014 | In Stock |
|
| 100MG | 1376 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2744 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUSP8-IN-22c
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.56 uM.
-
DescriptionA potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.56 uM; shows no inhibitory activity for USP7, USP5, SENP1, Uch-L3, and caspase 3 (IC50>100 uM), and displays partial activity against Uch-L3; inhibits the viability of HCT116 colon and PC-3 prostate cancer cell lines with IC50 values in the 0.5-1.5 uM range.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorDUB
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number924296-17-3
-
Formula Weight287.2756
-
Molecular FormulaC16H9N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20.1 mg/mL
-
SMILESC=CCON=C1C2=CC=CC=C2C3=NC(=C(N=C31)C#N)C#N
-
Chemical Name9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(2-propen-1-yloxy)imino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Colombo M, et al. ChemMedChem. 2010 Apr 6;5(4):552-8.
molnova catalog
related products
-
ML364
A potent, selective, reversible deubiquitinase USP2 inhibitor with IC50 of 1.1 uM in biochemical assay.
-
Ubiquitin Isopeptida...
A small molecule inhibitor of ubiquitin-proteasome system by inhibiting the ubiquitin isopeptidases.
-
USP8-IN-2
USP8-IN-2 is a potent inhibitor of the deubiquitinating enzymes USP7 and USP8, with an IC50 of 4.0 μM against USP8D. USP8-IN-2 is a potential compound for the treatment of cancer and viral infections.
